Publication
IDC MarketScape: Worldwide Life Science R&D Decentralized Clinical Trial Technology Solutions and Consulting Services 2024 Vendor Assessment
Feb 04, 2025

Explore the 2024 IDC MarketScape excerpt to gain insights into IQVIA's flexible DCT approaches for life sciences companies. This comprehensive report highlights the exceptional strengths of our portfolio, featuring purpose-built DCT technologies such as eCOA, eConsent, Study Hub, telemedicine, connected devices, and services like labs and home health nursing.

Our integrated strategy enables customers to adopt, run, and execute decentralized trial approaches, delivering a unique and differentiating experience.

Related solutions

Contact Us